ATE159424T1 - Verwendung von hydroxylierte carbonsäure zur behandlung von nägeln - Google Patents

Verwendung von hydroxylierte carbonsäure zur behandlung von nägeln

Info

Publication number
ATE159424T1
ATE159424T1 AT96401601T AT96401601T ATE159424T1 AT E159424 T1 ATE159424 T1 AT E159424T1 AT 96401601 T AT96401601 T AT 96401601T AT 96401601 T AT96401601 T AT 96401601T AT E159424 T1 ATE159424 T1 AT E159424T1
Authority
AT
Austria
Prior art keywords
carboxylic acid
hydroxylated carboxylic
nails
treat
treat nails
Prior art date
Application number
AT96401601T
Other languages
English (en)
Inventor
Jean-Claude Garson
Roland Ramin
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE159424T1 publication Critical patent/ATE159424T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96401601T 1995-07-31 1996-07-18 Verwendung von hydroxylierte carbonsäure zur behandlung von nägeln ATE159424T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509306A FR2737407B1 (fr) 1995-07-31 1995-07-31 Utilisation d'acides carboxyliques hydroxyles pour le traitement des matieres keratiniques

Publications (1)

Publication Number Publication Date
ATE159424T1 true ATE159424T1 (de) 1997-11-15

Family

ID=9481560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96401601T ATE159424T1 (de) 1995-07-31 1996-07-18 Verwendung von hydroxylierte carbonsäure zur behandlung von nägeln

Country Status (7)

Country Link
US (2) US5753211A (de)
EP (1) EP0756867B1 (de)
JP (1) JP2859583B2 (de)
AT (1) ATE159424T1 (de)
DE (1) DE69600084T2 (de)
ES (1) ES2112669T3 (de)
FR (1) FR2737407B1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974796B1 (en) * 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US20070231402A1 (en) * 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
FR2746003B1 (fr) * 1996-03-13 1998-04-30 Composition cosmetique a appliquer sur un support keratinique et utilisation
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US7790678B1 (en) 1999-08-17 2010-09-07 Immunopath Profile, Inc. Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
US20090274660A1 (en) 1999-08-17 2009-11-05 Immunopath Profile, Inc. Pluripotent therapeutic compositions and uses thereof
US20070037777A1 (en) * 2005-08-12 2007-02-15 Immunopath Profile, Inc. Lipid-containing compositions and methods of using them
US8679523B2 (en) 1999-12-30 2014-03-25 Kimberly-Clark Worldwide, Inc. Oxygen-delivery closed cell foam matrix for wound treatment
EP1261036A3 (de) * 2001-05-25 2004-07-28 Kabushiki Kaisha Toshiba Leistungs-MOSFET-Halbleiteranordnung und Verfahren zu deren Herstellung
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US6767553B2 (en) 2001-12-18 2004-07-27 Kimberly-Clark Worldwide, Inc. Natural fibers treated with acidic odor control/binder systems
US6852904B2 (en) 2001-12-18 2005-02-08 Kimberly-Clark Worldwide, Inc. Cellulose fibers treated with acidic odor control agents
CA2383296A1 (fr) * 2002-05-10 2003-11-10 Ginette Godbout Composition pour l'amelioration de la sante et de la structure des ongles, methode d'utilisation
US6921529B2 (en) * 2002-07-29 2005-07-26 Joseph C. Maley Treatment modality and method for fungal nail infection
US8486426B2 (en) * 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
US20040191195A1 (en) * 2003-03-28 2004-09-30 Carol Collins Method of promoting a nail composition
US20040191193A1 (en) * 2003-03-28 2004-09-30 Carol Collins Method of administering active agents into the nail
US7067076B2 (en) * 2003-08-01 2006-06-27 Rhodia Inc. Flame retardant phosphonate additives for thermoplastics
EP1781098B1 (de) 2004-07-30 2015-10-07 Avent, Inc. Antimikrobielle geräte und zusammensetzungen
BRPI0513967A (pt) 2004-07-30 2008-05-20 Acrymed Inc composições de prata antimicrobianas
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
US9289378B2 (en) 2004-09-20 2016-03-22 Avent, Inc. Antimicrobial amorphous compositions
EP2015722B1 (de) 2006-04-28 2016-11-16 Avent, Inc. Antimikrobielle verbände
WO2011071795A1 (en) * 2009-12-07 2011-06-16 Susanne Lang Fragrance Inc. Peelable, water-based nail cosmetic system
JP6777901B2 (ja) * 2016-08-02 2020-10-28 東洋紡株式会社 ネイルケア剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302442A (en) * 1979-09-28 1981-11-24 Usv Pharmaceutical Corporation Nail enamels
DE3101011C2 (de) * 1981-01-15 1985-06-05 Wella Ag, 6100 Darmstadt Haarbehandlungsmittel
JPS588007A (ja) * 1981-07-03 1983-01-18 Shiseido Co Ltd 皮膚柔軟化粧料
US4588590A (en) * 1981-12-21 1986-05-13 Jaye-Boern Laboratories, Inc. Method of treating keratosis and compositions useful therefor
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
EP0323798A3 (de) * 1987-12-02 1991-07-03 Colgate-Palmolive Company Milde, reinigende und konditionierende Zusammensetzung zur Erzielung einer zarten und weichen Haut
US5093108A (en) * 1989-02-16 1992-03-03 Amalia, Inc. Quick-drying nail enamel compositions and method for coating a surface
US4919920A (en) * 1989-03-15 1990-04-24 Devos John B Method of hardening and strengthening keratin and composition
GB9003201D0 (en) * 1990-02-13 1990-04-11 Unilever Plc Cosmetic composition
GB9021252D0 (en) * 1990-09-29 1990-11-14 Boots Co Plc Nail lacquers
EP0508324B1 (de) * 1991-04-10 1999-03-17 Ruey J. Dr. Yu Verwendung von 2-Hydroxycarbonsäure oder deren Derivaten enthaltende Zusammensetzung zur Linderung von Wechseln Nagelveränderungen
JPH0539211A (ja) * 1991-08-02 1993-02-19 Shiseido Co Ltd 人毛用還元剤及び人毛用化粧料
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
FR2714825B1 (fr) * 1994-01-11 1996-02-02 Oreal Compositions cosmétiques détergentes à usage capillaire et utilisation de ces dernières.
US5425938A (en) * 1994-01-28 1995-06-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds

Also Published As

Publication number Publication date
FR2737407A1 (fr) 1997-02-07
EP0756867B1 (de) 1997-10-22
US5753211A (en) 1998-05-19
JP2859583B2 (ja) 1999-02-17
JPH09104608A (ja) 1997-04-22
US5961996A (en) 1999-10-05
EP0756867A1 (de) 1997-02-05
ES2112669T3 (es) 1998-04-01
DE69600084D1 (de) 1997-11-27
FR2737407B1 (fr) 1997-09-12
DE69600084T2 (de) 1998-03-12

Similar Documents

Publication Publication Date Title
DE69600084D1 (de) Verwendung von hydroxylierte Carbonsäure zur Behandlung von Nägeln
DE69719408D1 (de) Verwendung von Strontiumsälze zur Behandlung von Arthrose
CA2081703A1 (en) Thrombin and method of producing the same
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
AU6998787A (en) Transglutaminase inhibitors
ATE215380T1 (de) Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
FI946185A0 (fi) Ligniinin polymerointi alkalisessa pH:ssa
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
ATE142884T1 (de) Verwendung von magnesium-pyridoxal-5'-phosphat- glutaminat zur verhinderung von krankheiten verursacht durch gefässläsionen
ATE173401T1 (de) Neue verwendung von 1-alpha-hydroxylierten-19-nor-vitamin-d-verbind ngen zur behandlung von psoriasis
ATE213414T1 (de) Verwendung von 2,4-diaminopyrimidin-3-oxyd und/oder seine salze zur behandlungvon störungen der kollagenreifung oder -strukturierung
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE212845T1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
DE59107536D1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
ATE174220T1 (de) Verwendung von leflunomid zur hemmung von interleukin 8
DE69522702D1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
NO179245C (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
DE59406002D1 (de) Verfahren zur Herstellung von 3-Hydroxy-2,4,5-trifluorbenzoesäurealkylestern und/oder 3-Alkoxy-2,4,5-trifluorbenzoesäurealkylestern
DE3881703D1 (de) Behandlung zur verbesserung der eigenschaften von keratintextilmaterialien.
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
ATE253852T1 (de) Zahnbürste zur verhinderung von zahnstein- zahnbelagbildung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties